Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer

Pancreas

Volumn 23, Issue 3, 2001, Pages 251-258

  Satoh, K ^a   Kaneko, K ^a   Hirota, M ^a   Masamune, A ^a   Satoh, A ^a   Shimosegawa, T ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Osteoprotegerin; Pancreatic cancer; TRAIL

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; CASPASE 8; OSTEOPROTEGERIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CLINICAL ARTICLE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, PANCREATIC DUCTAL; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; ENZYME ACTIVATION; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; PANCREAS; PANCREATIC NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034812354     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200110000-00005     Document Type: Article

References (36)

1. Fas ligand is frequently expressed in human pancreatic duct cell carcinoma
2. Human adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
3. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
4. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors
5. Identification and Characterization of new member of the TNF family that induces apoptosis
6. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
7. The receptor for the cytotoxic ligand TRAIL
8. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
9. Control of TRAILinduced apoptosis by a family of signaling and decoy receptors
10. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
11. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling
12. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
13. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
14. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
15. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
16. Pathology of nonendocrine pancreatic tumors
17. Oxidative stress induces NFkB DNA binding and inducible NOS mRNA in human epithelial cells
18. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
19. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL
20. Expression of TRAIL and its receptors in human brain tumors
21. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damageinducible gene that is overexpressed in primary tumors of the gastrointestinal tract
22. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
23. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKEL
24. An immunohistochemical study of the c-erb B-2 oncogene product in intraductal mucinhypersecreting neoplasms and in ductal cell carcinomas of the pancreas
25. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas
26. Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas
27. Expression of transforming growth factor β1(TGFβ1) and its receptors in pancreatic duct cell carcinoma and in chronic pancreatitis
28. TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells
29. Safety and antitumor activity of recombinant soluble Apo2 ligand
30. Molecular determinants of response to TRAIL in killing of normal and cancer cells
31. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by chemotherapeutic agent CPT-11
32. Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells
33. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
34. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosisinducing ligand
35. Serum-free, long-term cultures of human hepatocytes: Maintenance of cell morphology, transcription factors, and liver-specific functions